Fig. 7From: Potentiating humoral and cellular immunity using a novel hybrid polymer-lipid nanoparticle adjuvant for HBsAg-VLP vaccineA The serum IL-6, B IL-4, C IFN-γ and D Gzms-B concentration after the second boost of different vaccine formulations on Day 42 in mice. One-way ANOVA was used for statistical analyseBack to article page